Pharmsville Co., Ltd. (KOSDAQ:318010)
South Korea
· Delayed Price · Currency is KRW 3,390.00
+10.00 (0.30%)
At close: Mar 31, 2025, 3:30 PM KST
Pharmsville Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2017 |
| Other Revenue | -0 | -0 | - | - | 0 | Upgrade
|
| Revenue | 16,725 | 21,395 | 26,113 | 39,028 | 39,409 | Upgrade
|
| Revenue Growth (YoY) | -21.83% | -18.07% | -33.09% | -0.97% | 31.57% | Upgrade
|
| Cost of Revenue | 6,224 | 8,253 | 10,290 | 13,266 | 11,977 | Upgrade
|
| Gross Profit | 10,501 | 13,142 | 15,823 | 25,762 | 27,432 | Upgrade
|
| Selling, General & Admin | 9,051 | 9,071 | 9,811 | 18,147 | 22,073 | Upgrade
|
| Research & Development | 1,482 | 2,187 | 1,661 | 1,189 | 812.07 | Upgrade
|
| Other Operating Expenses | 136.39 | 119.08 | 169.11 | 108.1 | 111.59 | Upgrade
|
| Operating Expenses | 10,771 | 11,499 | 11,761 | 19,614 | 23,125 | Upgrade
|
| Operating Income | -269.85 | 1,643 | 4,063 | 6,147 | 4,306 | Upgrade
|
| Interest Expense | -44.27 | -150.37 | -152.86 | -74.18 | -95.61 | Upgrade
|
| Interest & Investment Income | 484.17 | 798.35 | 839.1 | 413.13 | 401.31 | Upgrade
|
| Earnings From Equity Investments | - | -63.31 | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | 30.03 | 1.65 | 13.09 | 15.67 | -11.22 | Upgrade
|
| Other Non Operating Income (Expenses) | 1,214 | 1,368 | 846.73 | 465.41 | 208.03 | Upgrade
|
| EBT Excluding Unusual Items | 1,415 | 3,597 | 5,609 | 6,968 | 4,809 | Upgrade
|
| Gain (Loss) on Sale of Investments | 415.33 | 403.42 | -458.66 | -803.26 | -1,339 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | -33.82 | 41.82 | - | -27.67 | Upgrade
|
| Pretax Income | 1,830 | 3,966 | 5,192 | 6,164 | 3,442 | Upgrade
|
| Income Tax Expense | 246.71 | 659.32 | 1,128 | 1,168 | 572.63 | Upgrade
|
| Earnings From Continuing Operations | 1,583 | 3,307 | 4,064 | 4,996 | 2,870 | Upgrade
|
| Minority Interest in Earnings | -0.1 | 2.42 | -0.74 | 3.53 | 21.92 | Upgrade
|
| Net Income | 1,583 | 3,310 | 4,063 | 5,000 | 2,891 | Upgrade
|
| Net Income to Common | 1,583 | 3,310 | 4,063 | 5,000 | 2,891 | Upgrade
|
| Net Income Growth | -52.17% | -18.54% | -18.74% | 72.92% | -60.15% | Upgrade
|
| Shares Outstanding (Basic) | 8 | 8 | 8 | 8 | 8 | Upgrade
|
| Shares Outstanding (Diluted) | 8 | 8 | 8 | 8 | 8 | Upgrade
|
| Shares Change (YoY) | -1.30% | -0.29% | - | -0.29% | 18.53% | Upgrade
|
| EPS (Basic) | 205.00 | 423.00 | 517.79 | 637.23 | 367.42 | Upgrade
|
| EPS (Diluted) | 205.00 | 423.00 | 517.79 | 637.00 | 367.00 | Upgrade
|
| EPS Growth | -51.54% | -18.31% | -18.71% | 73.57% | -66.42% | Upgrade
|
| Free Cash Flow | -372.74 | 4,450 | 5,083 | 7,982 | -3,459 | Upgrade
|
| Free Cash Flow Per Share | -48.27 | 568.75 | 647.87 | 1017.25 | -439.51 | Upgrade
|
| Dividend Per Share | - | - | 100.000 | 100.000 | 100.000 | Upgrade
|
| Dividend Growth | - | - | - | - | -50.00% | Upgrade
|
| Gross Margin | 62.79% | 61.43% | 60.59% | 66.01% | 69.61% | Upgrade
|
| Operating Margin | -1.61% | 7.68% | 15.56% | 15.75% | 10.93% | Upgrade
|
| Profit Margin | 9.46% | 15.47% | 15.56% | 12.81% | 7.34% | Upgrade
|
| Free Cash Flow Margin | -2.23% | 20.80% | 19.47% | 20.45% | -8.78% | Upgrade
|
| EBITDA | 405.04 | 2,319 | 4,734 | 6,364 | 4,521 | Upgrade
|
| EBITDA Margin | 2.42% | 10.84% | 18.13% | 16.31% | 11.47% | Upgrade
|
| D&A For EBITDA | 674.9 | 675.99 | 671.39 | 216.32 | 214.54 | Upgrade
|
| EBIT | -269.85 | 1,643 | 4,063 | 6,147 | 4,306 | Upgrade
|
| EBIT Margin | -1.61% | 7.68% | 15.56% | 15.75% | 10.93% | Upgrade
|
| Effective Tax Rate | 13.48% | 16.62% | 21.73% | 18.95% | 16.64% | Upgrade
|
| Advertising Expenses | 1,727 | 865.93 | 843.02 | 3,230 | 4,275 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.